Heghine Khachatryan: What Is Your Position on the Voluntary or Financially Compensated Blood Donation Model
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post on LinkedIn:
“Blood donation remains one of the most essential pillars of modern healthcare.
Yet, the sustainability of blood supplies continues to challenge healthcare systems worldwide, raising important ethical and practical questions.
As healthcare professionals, researchers, and transfusion specialists, your perspective is invaluable.
Discussion Question
Should blood donation remain a completely voluntary, non-remunerated act, or should financial compensation for donors be considered under specific circumstances?
Please share your opinion and the reasoning behind it.
Option 1 – Voluntary, Non-Remunerated Blood Donation (Supported by WHO)
- Promotes altruism, solidarity, and public trust.
- Is generally associated with the lowest risk of transfusion-transmissible infections.
- Reduces the possibility that financial need may influence donor eligibility or disclosure of risk factors.
- Supports a sustainable culture of regular, repeat voluntary donors.
Option 2 – Financially Compensated Donation
- May increase donor recruitment during periods of blood shortages.
- Could improve the availability of plasma or blood components in regions facing chronic supply deficits.
- May acknowledge the donor’s time, travel expenses, and inconvenience.
- Raises ethical concerns regarding equity, exploitation of economically vulnerable populations, and potential impacts on donor safety and blood quality.
There is no universally simple answer. Different countries have adopted different models, each with unique ethical, clinical, and public health implications.
What is your position?
- I support exclusively voluntary, non-remunerated donation.
- I support carefully regulated financial compensation.
- I believe a hybrid model is the most appropriate.
Please explain the evidence, ethical principles, or clinical experience that has shaped your opinion. An open, respectful discussion can help advance transfusion medicine and strengthen future blood donation policies.”
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Jul 2, 2026, 11:52Praveen Kumar Tirlangi: A New Mechanism of Bleeding in Kyasanur Forest Disease
-
Jul 2, 2026, 11:17Heghine Khachatryan: Novel Biomarkers for Cancer-Associated Thrombosis
-
Jul 2, 2026, 11:17Neeraj Jain: Maharashtra Is Setting the Pace for Integrated Hemoglobinopathy Care
-
Jul 2, 2026, 11:11Safaa Hilal: Improving Postpartum Hemorrhage Outcomes Through Early Warning Scores
-
Jul 2, 2026, 11:10Maria Khan Junaidi: How Age Influences Intracerebral Hemorrhage Outcomes
-
Jul 2, 2026, 10:51Faces of Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jul 2, 2026, 10:44Priya Sriskandarajah: Understanding Anemia of Chronic Disease in Clinical Practice
-
Jul 2, 2026, 10:42Flora Peyvandi: Germline-Targeting Vaccines for HIV
-
Jul 2, 2026, 10:29Nisar Ahmed: The Evolution of Anticoagulation Therapy